To investigate this question, we used a staged sequencing approach using 45 deeply sequenced CBF-AML RNA-Seq samples from the Leucegene study [9], where mutations had been validated on matched DNA samples. This evidence concerns the gene CEBPZ and acute myeloid leukemia.